Hamamura, Kazunori <br/><br/>
Suppression of osteoclastogenesis through phosphorylation of eukaryotic translation initiation factor 2 alpha.  [electronic resource] 

 -  Journal of bone and mineral metabolism  Nov 2013 
 - 618-28 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1435-5604 
<br/><br/><label>Standard No.: </label>10.1007/s00774-013-0450-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acid Phosphatase--genetics<br/>Activating Transcription Factor 4--genetics<br/>Animals<br/>Cells, Cultured<br/>Cinnamates--pharmacology<br/>Down-Regulation--drug effects<br/>Eukaryotic Initiation Factor-2--genetics<br/>Genes, fos--genetics<br/>Guanabenz--pharmacology<br/>Isoenzymes--genetics<br/>Mice<br/>NFATC Transcription Factors--genetics<br/>Osteoblasts--drug effects<br/>Osteocalcin--metabolism<br/>Osteoclasts--drug effects<br/>Osteogenesis--drug effects<br/>Osteoporosis--genetics<br/>Phosphorylation--drug effects<br/>RNA, Messenger--genetics<br/>Receptors, Cell Surface--genetics<br/>Tartrate-Resistant Acid Phosphatase<br/>Thiourea--analogs & derivatives